Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for Inhibrx Biosciences (INBX) over the last 1 years, with Sep 2025 value amounting to -0.05.

  • Inhibrx Biosciences' Asset Utilization Ratio was N/A to -0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05, marking a year-over-year change of. This contributed to the annual value of 0.00 for FY2024, which is N/A change from last year.
  • Per Inhibrx Biosciences' latest filing, its Asset Utilization Ratio stood at -0.05 for Q3 2025, which was up 6.22% from -0.05 recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' Asset Utilization Ratio peaked at -0.05 during Q3 2025, and registered a low of -0.08 during Q1 2025.
  • For the 2-year period, Inhibrx Biosciences' Asset Utilization Ratio averaged around -0.06, with its median value being -0.05 (2024).